收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 A drug safety evaluation of enzalutamide to treat advanced prostate cancer Fred Saad, Zineb Hamilou, Jean-Baptiste Lattouf 741
2 Newer formulations of intravenous iron: a review of their chemistry and key safety aspects - hypersensitivity, hypophosphatemia, and cardiovascular safety Irina Blumenstein, Satish Shanbhag, Peter Langguth... 757
3 Current and emerging long-acting antipsychotics for the treatment of schizophrenia Renato de Filippis, Pasquale De Fazio, Raffaele Gaetano... 771
4 The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia Giovanni Marconi, Maria Benedetta Giannini, Gianmarco Bagnato... 791
5 Safety of topical interventions for the treatment of actinic keratosis Elias A. T. Koch, Anja Wessely, Theresa Steeb... 801
6 Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU Dianne Butler, Katarina Vucic, Sabine Straus... 815
7 A reappraisal of the role of fever in the occurrence of neurological sequelae following lithium intoxication: a systematic review Hélène Verdoux, Anne-Laure Debruyne, Emmanuelle Queuille... 827
8 Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study Massimo Zuin, Alessio Aghemo, Nicola Pugliese... 839
9 Assessment of suspected adverse drug reactions in elderly patients with diabetes mellitus based on a Portuguese spontaneous reporting database: analysis of reporting from 2008 to 2018 Cristina Monteiro, Samuel Silvestre, Ana Paula Duarte... 845
10 Investigating the root cause of N-nitrosodimethylamine formation in metformin pharmaceutical products Nasr Eldin Hussein Nasr, Metwaly Gamel Metwaly, Eman Osama Ahmed... 855